Reactions Weekly

, Volume 1695, Issue 1, pp 288–288 | Cite as

Ombitasvir/paritaprevir/ritonavir

Fatal liver failure, hepatic encephalopathy and variceal bleeding: 3 case reports
Case report
First Online:
  • 11 Downloads
This is a preview of subscription content, log in to check access

Reference

  1. Perello C, et al. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir +/- dasabuvir +/- ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection. Journal of Viral Hepatitis 24: 226-237, No. 3, Mar 2017. Available from: URL: http://doi.org/10.1111/jvh.12637 - SpainCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations